MicroRNA-181a suppresses parkin-mediated mitophagy and sensitizes neuroblastoma cells to mitochondrial uncoupler-induced apoptosis

Oncotarget

Volumn 7, Issue 27, 2016, Pages 42274-42287

  Cheng, Min ^a   Liu, Lei ^a   Lao, Yuanzhi ^b   Liao, Weijie ^a   Liao, Meijian ^a   Luo, Xuan ^a   Wu, Jiangbin ^a   Xie, Weidong ^a   Zhang, Yaou ^a   Xu, Naihan ^a  

^a TSINGHUA UNIVERSITY   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Apoptosis; MicroRNA; Mitochondria; Mitophagy; Parkin

Indexed keywords

MICRORNA; MIRN181 MICRORNA, HUMAN; MITOCHONDRIAL DNA; PARKIN; UBIQUITIN PROTEIN LIGASE; UNCOUPLING PROTEIN;

APOPTOSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; LYSOSOME; METABOLISM; MITOCHONDRION; MITOPHAGY; NEUROBLASTOMA; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; DNA, MITOCHONDRIAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYSOSOMES; MICRORNAS; MITOCHONDRIA; MITOCHONDRIAL DEGRADATION; MITOCHONDRIAL UNCOUPLING PROTEINS; NEUROBLASTOMA; UBIQUITIN-PROTEIN LIGASES;

EID: 85034454508     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.9786     Document Type: Article

References (52)

1. McBride H M, M Neuspiel, S Wasiak. Mitochondria: more than just a powerhouse. Curr Biol. 2006; 16:R551-60.
2. MacVicar T. Mitophagy. Essays Biochem. 2013; 55: 93-104.
3. Wei H, L Liu, Q Chen. Selective removal of mitochondria via mitophagy: distinct pathways for different mitochondrial stresses. Biochim Biophys Acta. 2015; 1853:2784-90.
4. Chan D C. Mitochondria: dynamic organelles in disease, aging, and development. Cell. 2006; 125:1241-52.
5. de Vries R L, S Przedborski. Mitophagy and Parkinson's disease: be eaten to stay healthy. Mol Cell Neurosci. 2013; 55: 37-43.
6. Boland M L, A H Chourasia, K F Macleod. Mitochondrial dysfunction in cancer. Front Oncol. 2013; 3:292.
7. Scheibye-Knudsen M, E F Fang, D L Croteau, D M Wilson, 3rd, V A Bohr. Protecting the mitochondrial powerhouse. Trends Cell Biol. 2015; 25:158-70.
8. Rugarli E I, T Langer. Mitochondrial quality control: a matter of life and death for neurons. EMBO J. 2012; 31:1336-49.
9. Lemasters J J. Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction, and aging. Rejuvenation Res. 2005; 8:3-5.
10. Ashrafi G, T L Schwarz. The pathways of mitophagy for quality control and clearance of mitochondria. Cell Death Differ. 2013; 20:31-42.
11. Durcan T M, E A Fon. The three 'P's of mitophagy: PARKIN, PINK1, and post-translational modifications. Genes Dev. 2015; 29:989-99.
12. Narendra D, A Tanaka, D F Suen, R J Youle. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol. 2008; 183:795-803.
13. Liu L, D Feng, G Chen, M Chen, Q Zheng, P Song, Q Ma, C Zhu, R Wang, W Qi, L Huang, P Xue, B Li, et al. Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells. Nat Cell Biol. 2012; 14:177-85.
14. Novak I, V Kirkin, D G McEwan, J Zhang, P Wild, A Rozenknop, V Rogov, F Lohr, D Popovic, A Occhipinti, A S Reichert, J Terzic, V Dotsch, et al. Nix is a selective autophagy receptor for mitochondrial clearance. EMBO Rep. 2010; 11:45-51.
15. Kitada T, S Asakawa, N Hattori, H Matsumine, Y Yamamura, S Minoshima, M Yokochi, Y Mizuno, N Shimizu. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998; 392:605-8.
16. Lucking C B, A Durr, V Bonifati, J Vaughan, G De Michele, T Gasser, B S Harhangi, G Meco, P Denefle, N W Wood, Y Agid, A Brice, G French Parkinson's Disease Genetics Study, et al. Association between early-onset Parkinson's disease and mutations in the parkin gene. N Engl J Med. 2000; 342:1560-7.
17. Valente E M, P M Abou-Sleiman, V Caputo, M M Muqit, K Harvey, S Gispert, Z Ali, D Del Turco, A R Bentivoglio, D G Healy, A Albanese, R Nussbaum, R Gonzalez- Maldonado, et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science. 2004; 304:1158-60.
18. Shimura H, N Hattori, S Kubo, Y Mizuno, S Asakawa, S Minoshima, N Shimizu, K Iwai, T Chiba, K Tanaka, T Suzuki. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet. 2000; 25:302-5.
19. Greene J C, A J Whitworth, I Kuo, L A Andrews, M B Feany, L J Pallanck. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc Natl Acad Sci U S A. 2003; 100:4078-83.
20. Park J, S B Lee, S Lee, Y Kim, S Song, S Kim, E Bae, J Kim, M Shong, J M Kim, J Chung. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature. 2006; 441:1157-61.
21. Meissner C, H Lorenz, A Weihofen, D J Selkoe, M K Lemberg. The mitochondrial intramembrane protease PARL cleaves human Pink1 to regulate Pink1 trafficking. J Neurochem. 2011; 117:856-67.
22. Deas E, H Plun-Favreau, S Gandhi, H Desmond, S Kjaer, S H Loh, A E Renton, R J Harvey, A J Whitworth, L M Martins, A Y Abramov, N W Wood. PINK1 cleavage at position A103 by the mitochondrial protease PARL. Hum Mol Genet. 2011; 20:867-79.
23. Greene A W, K Grenier, M A Aguileta, S Muise, R Farazifard, M E Haque, H M McBride, D S Park, E A Fon. Mitochondrial processing peptidase regulates PINK1 processing, import and Parkin recruitment. EMBO Rep. 2012; 13:378-85.
24. Narendra D P, S M Jin, A Tanaka, D F Suen, C A Gautier, J Shen, M R Cookson, R J Youle. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol. 2010; 8:e1000298.
25. Sarraf S A, M Raman, V Guarani-Pereira, M E Sowa, E L Huttlin, S P Gygi, J W Harper. Landscape of the PARKINdependent ubiquitylome in response to mitochondrial depolarization. Nature. 2013; 496:372-6.
26. Schwarten M, J Mohrluder, P Ma, M Stoldt, Y Thielmann, T Stangler, N Hersch, B Hoffmann, R Merkel, D Willbold. Nix directly binds to GABARAP: a possible crosstalk between apoptosis and autophagy. Autophagy. 2009; 5:690-8.
27. Kanki T. Nix, a receptor protein for mitophagy in mammals. Autophagy. 2010; 6:433-5.
28. Frankel L B, A H Lund. MicroRNA regulation of autophagy. Carcinogenesis. 2012; 33:2018-25.
29. Jing Z, W Han, X Sui, J Xie, H Pan. Interaction of autophagy with microRNAs and their potential therapeutic implications in human cancers. Cancer Lett. 2015; 356:332-8.
30. Barde I, B Rauwel, R M Marin-Florez, A Corsinotti, E Laurenti, S Verp, S Offner, J Marquis, A Kapopoulou, J Vanicek, D Trono. A KRAB/KAP1-miRNA cascade regulates erythropoiesis through stage-specific control of mitophagy. Science. 2013; 340:350-3.
31. Li W, X Zhang, H Zhuang, H G Chen, Y Chen, W Tian, W Wu, Y Li, S Wang, L Zhang, Y Chen, L Li, B Zhao, et al. MicroRNA-137 is a novel hypoxia-responsive microRNA that inhibits mitophagy via regulation of two mitophagy receptors FUNDC1 and NIX. J Biol Chem. 2014; 289:10691-701.
32. Zhao J, Y Nie, H Wang, Y Lin. MiR-181a suppresses autophagy and sensitizes gastric cancer cells to cisplatin. Gene. 2016; 576:828-33.
33. Tekirdag K A, G Korkmaz, D G Ozturk, R Agami, D Gozuacik. MIR181A regulates starvation- and rapamycininduced autophagy through targeting of ATG5. Autophagy. 2013; 9:374-85.
34. Wei J L, Y C Li, Z L Ma, Y X Jin. MiR-181a-5p promotes anoikis by suppressing autophagy during detachment induction in the mammary epithelial cell line MCF10A. Protein Cell. 2016; 7:305-9.
35. Cai Q, H M Zakaria, A Simone, Z H Sheng. Spatial parkin translocation and degradation of damaged mitochondria via mitophagy in live cortical neurons. Curr Biol. 2012; 22:545-52.
36. Tanaka A, M M Cleland, S Xu, D P Narendra, D F Suen, M Karbowski, R J Youle. Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. J Cell Biol. 2010; 191:1367-80.
37. Xu S, G Peng, Y Wang, S Fang, M Karbowski. The AAAATPase p97 is essential for outer mitochondrial membrane protein turnover. Mol Biol Cell. 2011; 22:291-300.
38. Karbowski M, R J Youle. Regulating mitochondrial outer membrane proteins by ubiquitination and proteasomal degradation. Curr Opin Cell Biol. 2011; 23:476-82.
39. Miska E A, E Alvarez-Saavedra, M Townsend, A Yoshii, N Sestan, P Rakic, M Constantine-Paton, H R Horvitz. Microarray analysis of microRNA expression in the developing mammalian brain. Genome Biol. 2004; 5:R68.
40. Chen C Z, L Li, H F Lodish, D P Bartel. MicroRNAs modulate hematopoietic lineage differentiation. Science. 2004; 303:83-6.
41. Shi L, Z Cheng, J Zhang, R Li, P Zhao, Z Fu, Y You. hsamir- 181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Res. 2008; 1236: 185-93.
42. Gibert B, C Delloye-Bourgeois, C H Gattolliat, O Meurette, S Le Guernevel, J Fombonne, B Ducarouge, F Lavial, F Bouhallier, M Creveaux, A M Negulescu, J Benard, I Janoueix-Lerosey, et al. Regulation by miR181 family of the dependence receptor CDON tumor suppressive activity in neuroblastoma. J Natl Cancer Inst. 2014; 106.
43. Gandhi S, A Wood-Kaczmar, Z Yao, H Plun-Favreau, E Deas, K Klupsch, J Downward, D S Latchman, S J Tabrizi, N W Wood, M R Duchen, A Y Abramov. PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death. Mol Cell. 2009; 33:627-38.
44. Piccoli C, A Sardanelli, R Scrima, M Ripoli, G Quarato, A D'Aprile, F Bellomo, S Scacco, G De Michele, A Filla, A Iuso, D Boffoli, N Capitanio, et al. Mitochondrial respiratory dysfunction in familiar parkinsonism associated with PINK1 mutation. Neurochem Res. 2008; 33:2565-74.
45. Liu W, C Vives-Bauza, R Acin-Perez, A Yamamoto, Y Tan, Y Li, J Magrane, M A Stavarache, S Shaffer, S Chang, M G Kaplitt, X Y Huang, M F Beal, et al. PINK1 defect causes mitochondrial dysfunction, proteasomal deficit and alpha-synuclein aggregation in cell culture models of Parkinson's disease. PLoS One. 2009; 4:e4597.
46. Gautier C A, E Giaime, E Caballero, L Nunez, Z Song, D Chan, C Villalobos, J Shen. Regulation of mitochondrial permeability transition pore by PINK1. Mol Neurodegener. 2012; 7:22.
47. Mortiboys H, K J Thomas, W J Koopman, S Klaffke, P Abou-Sleiman, S Olpin, N W Wood, P H Willems, J A Smeitink, M R Cookson, O Bandmann. Mitochondrial function and morphology are impaired in parkin-mutant fibroblasts. Ann Neurol. 2008; 64:555-65.
48. Jiang H, Y Ren, J Zhao, J Feng. Parkin protects human dopaminergic neuroblastoma cells against dopamineinduced apoptosis. Hum Mol Genet. 2004; 13:1745-54.
49. Hyun D H, M Lee, N Hattori, S Kubo, Y Mizuno, B Halliwell, P Jenner. Effect of wild-type or mutant Parkin on oxidative damage, nitric oxide, antioxidant defenses, and the proteasome. J Biol Chem. 2002; 277:28572-7.
50. Kuroda Y, T Mitsui, M Kunishige, T Matsumoto. Parkin affects mitochondrial function and apoptosis in neuronal and myogenic cells. Biochem Biophys Res Commun. 2006; 348:787-93.
51. Ouyang Y B, Y Lu, S Yue, R G Giffard. miR-181 targets multiple Bcl-2 family members and influences apoptosis and mitochondrial function in astrocytes. Mitochondrion. 2012; 12:213-9.
52. Galluzzi L, E Morselli, I Vitale, O Kepp, L Senovilla, A Criollo, N Servant, C Paccard, P Hupe, T Robert, H Ripoche, V Lazar, A Harel-Bellan, et al. miR-181a and miR-630 regulate cisplatin-induced cancer cell death. Cancer Res. 2010; 70:1793-803.